Uncategorized
Advertisement
Dr. Jain spoke to the rationale for combining erdafitinib with EV in mUC patients with FGFR3/2 genetic alterations.
Dr. Thompson, Jr. highlights his recently published large dataset of long-term complications of prostate cancer treatment.
Dr. Jason Hafron provides a detailed real-world explanation of reimbursement considerations for Jelmyto (mitomycin).
Dr. Vandekerkhove explains her research on genomic testing in prostate cancer.
Dr. Plimack provides a summary of her presentation at the SUO Annual Meeting on the progress of ADCs in UC research.
Several urologists weigh in on BCG, its role in NMIBC treatment, shortages, and strategies to treat BCG-unresponsive disease.
Joshua Meeks, MD, PhD, discusses ongoing research in NMIBC and the future of urothelial carcinoma care.
5-ARIs, used in the treatment of benign prostatic hyperplasia and androgenic alopecia, may be associated with depression.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.